NCT07226908

Human Thalamus in Propagation of Temporal Lobe Seizures and Memory Formation

Enrolling by Invitation
NAAges 18–65InterventionalBasic science
Stanford University
~100 participants
Updated 2025-11-12 on ClinicalTrials.gov
What's tested:Cognitive experimentElectrical stimulation of the brain

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Cerebro-cerebral evoked potentials
Measured over During experiment up to 2 weeks
+5 more outcomes measured
Epilepsy
1 sites across 1 states
California1
  • Josef Parvizi, MD PhD · PRINCIPAL_INVESTIGATOR · Stanford University

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

No medical or surgical contraindication to electrode implantation
Patient capable of understanding the scope of our project or signing informed consent independently

Exclusion

Unable to provide informed consent
  • Cerebro-cerebral evoked potentialsDuring experiment up to 2 weeks

    To map thalamocortical and corticothalamic causal effective connectivity, the study team will use the well-known method of repeated single electrical pulse stimulation with intracranial EEG. Study team will measure the amplitude and timing to first peak of cerebro-cerebral evoked potentials (CCEPs).

  • fMRI BOLD activityDuring experiment up to 2 weeks

    To map thalamocortical and corticothalamic functional connectivity, he study team will obtain 8 runs of 6mins resting state fMRIs. Study team will measure the correlation of BOLD activity across voxels of interest.

  • Epileptogenicity Index (EI)During experiment up to 2 weeks

    The study team will identify seizure onset zones (SOZs) using the measure of Epileptogenicity Index (EI) applied to data collected through intracranial EEG, and will label the SOZs as medial temporal lobe epilepsy (mTLE) versus nonmedial TLEs.

  • Seizure propagationDuring experiment up to 2 weeks

    Seizure propagation to ANT and PLV will be examined through intracranial EEG data within individuals by measuring EI and the propagation latencies from SOZ to ANT and PLV recording sites will be noted.

  • Coordinated activity across HPC and ANTDuring experiment up to 2 weeks

    Successful memory encoding is associated with coordinated activity across hippocampus (HPC) and ANT (i.e., high frequency activity in ANT locked to the phase of hippocampal theta). Using intracranial EEG data, the study team will follow traditional analyses of changes in power in the canonical EEG bands (e.g., 3-7 Hz, theta band, 40-150 Hz, high gamma, etc.) as well as computationally derived aperiodic features of the signal \[i.e., using the fitting oscillations \& one over f (FOOOF) function\]. Response onset latency of neural activity will determine with simultaneous recordings across HPC, ANT, and PLV how each ROI is engaged in time during a given experimental condition (i.e., encoding trials later recalled and trials not later recalled). We will also use validated methods of phase amplitude coupling (PAC) and intersite phase coherence (ISPC) to quantify cross regional relationships.

  • Cognitive task performanceDuring experiment up to 2 weeks

    In total, each patient will be asked to encode 200 words across the 5 sessions.